LEP and fatty liver disease: In line with the observed excess adiposity and hepatic steatosis, leptin-deficient mice exhibited higher Pparg mRNA levels in the adipose tissue and liver that were reduced by leptin replacement and, to a lesser extent, by caloric restriction (Fig. 4A,B).